CytomX Therapeutics is a clinical-stage biopharmaceutical company founded in 2008, focused on advancing cancer treatment through innovative therapies. Headquartered in the U.S., the company specializes in Probody® therapeutics, a proprietary technology that enhances the safety and effectiveness of cancer treatments by selectively activating therapies within the tumor microenvironment. The Prob...